|
|
||||||||
Journal of Applied Physiology, Vol 74, Issue 4 1672-1678, Copyright © 1993 by American Physiological Society
ARTICLES |
D. D. Malcolm, J. L. Segar, J. E. Robillard and S. Chemtob
Department of Pediatrics, University of Iowa, Iowa City 52242.
We examined whether prostanoids contribute to the impaired cardiac function and decrease in regional blood flow induced by increasing mean airway pressure. Using microspheres, we measured cardiac output and major organ blood flow and assayed prostaglandin E2, 6-ketoprostaglandin F1 alpha, and thromboxane B2 in blood at mean airway pressures of 5-25 cmH2O in mechanically ventilated newborn piglets treated with ibuprofen (40 mg/kg, n = 6), indomethacin (0.3 mg/kg, n = 6), or vehicle (n = 6). Blood gases and pH were stable throughout the experiments. Prostanoid levels remained constant with increasing mean airway pressure in vehicle-treated pigs and were unchanged by indomethacin. However, ibuprofen decreased the prostanoid levels at all mean airway pressures studied (P < 0.01). As ventilatory pressure was progressively increased, cardiac output decreased gradually and similarly by 42-45% (P < 0.05) in all groups. At the highest mean airway pressure, blood flow decreased to the kidneys by 37-57%, to the ileum by 58-74%, and to the colon by 53-71% (P < 0.05) in all groups. Cerebral blood flow remained constant at all ventilatory pressures regardless of the treatment. There was no difference in cardiac output and regional hemodynamics between ibuprofen- and vehicle-treated animals. However, after indomethacin, ileal blood flow at the higher ventilatory pressures was 41-46% lower and cerebral blood flow at all mean airway pressures was 14-25% lower than after the other treatments (P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
B-H Su, H-C Lin, H-Y Chiu, H-Y Hsieh, H-H Chen, and Y-C Tsai Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2008; 93(2): F94 - F99. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dani, G. Bertini, M. Pezzati, C. Poggi, P. Guerrini, C. Martano, F. F. Rubaltelli, and and the IntraVentricular Ibuprofen Study Group Prophylactic Ibuprofen for the Prevention of Intraventricular Hemorrhage Among Preterm Infants: A Multicenter, Randomized Study Pediatrics, June 1, 2005; 115(6): 1529 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Heyman, I. Morag, D. Batash, R. Keidar, S. Baram, and M. Berkovitch Closure of Patent Ductus Arteriosus With Oral Ibuprofen Suspension in Premature Newborns: A Pilot Study Pediatrics, November 1, 2003; 112(5): e354 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Overmeire, K. Smets, D. Lecoutere, H. Van de Broek, J. Weyler, K. De Groote, and J.-P. Langhendries A Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus N. Engl. J. Med., September 7, 2000; 343(10): 674 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Clyman Ibuprofen and Patent Ductus Arteriosus N. Engl. J. Med., September 7, 2000; 343(10): 728 - 730. [Full Text] |
||||
![]() |
B. Van Overmeire, I. Follens, S. Hartmann, W. L Creten, and K. J Van Acker Treatment of patent ductus arteriosus with ibuprofen Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1997; 76(3): 179F - 184. [Abstract] [Full Text] |
||||
![]() |
K. G. Peri, P. Hardy, D. Y. Li, D. R. Varma, and S. Chemtob Prostaglandin G/H Synthase-2 Is a Major Contributor of Brain Prostaglandins in the Newborn J. Biol. Chem., October 13, 1995; 270(41): 24615 - 24620. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |